NAMSDL is a 501(c)(3) nonprofit organization dedicated to comprehensive, integrative and effective state drug laws, policies and programs

Model Act Providing for the Warm Hand-off of Overdose Survivors to Treatment

A new model law that requires use of the most effective practices to transfer stabilized overdose survivors directly and immediately to clinically appropriate treatment and recovery support services.

Model Controlled Substance Analogue Act

As part of the Novel Psychoactive Substances (NPS) Model Law Package, this updated law improves on current laws by clarifying the “analogue” definition and highlighting factors that indicate an emerging substance should be treated as one.

Model Expedited Scheduling of Controlled Substances Act

As part of the Novel Psychoactive Substances (NPS) Model Law Package, this updated law establishes a streamlined process to temporarily schedule emerging NPS for 18-24 months.

Model Scheduling New/Novel Psychoactive Substances Act

As part of the Novel Psychoactive Substances (NPS) Model Law Package, this updated law provides comprehensive, up-to-date language for scheduling emerging NPS, using structural class definitions where possible.

Model Universal Access to Naloxone Act

An updated model law to reduce opioid overdose deaths that makes naloxone universally available to first responders and the general public. The act also ensures comprehensive financial support for naloxone.

Prescription Drug Monitoring Programs

Prescription Drug Monitoring Programs (PDMPs) are critical decision support tools that state officials, health care professionals, and law enforcement officers use to address opioid and   prescription drug abuse and diversion. PDMPs electronically collect, analyze and disclose specified information about prescribed controlled substances and other monitored substances dispensed to patients and their representatives. 

Novel Psychoactive Substances

Novel Psychoactive Substances (NPS), commonly referred to as synthetic drugs or designer drugs, include substances such as synthetic cannabinoids (“spice”), substituted cathinones (“bath salts”), and fentanyl analogues. NPS are manufactured by chemists to mimic the effects of other, often illegal, drugs. The resulting substances can have stronger or different effects on humans than the mimicked drug. Because many NPS are created in unregulated labs, the exact chemical composition of a particular NPS may be unknown to the user.

Drugged Driving

Drugged Driving is the act of driving a motor vehicle illegally after consuming an impairing substance other than alcohol. As with alcohol, drugged driving can occur when a driver exhibits signs of driving while under the influence or while impaired by a drug. Drugged driving may also if a driver operates a vehicle with more than a specified amount of a drug in their bloodstream, where such specified amount may be anything above zero. State laws differ substantially in the types of drugs covered by these laws, which run the gamut from substances illegal in all states (such heroin) to controlled substances whose legality varies (such as marijuana) to widely used over-the-counter substances (such as pseudoephedrine).